查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464658

诊断放射性同位素市场，按放射性同位素、按应用、按成像方式、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年诊断放射性同位素市场规模为58.2021亿美元，2024年至2032年复合年增长率为9.81%。

诊断放射性同位素市场-市场动态

慢性病盛行率上升预计将推动市场成长

癌症、心臟病和神经系统疾病等慢性疾病通常需要频繁的诊断影像来监测疾病进展、评估治疗效果和识别復发。诊断放射性同位素在正子断层扫描 (PET)、单光子发射电脑断层扫描 (SPECT) 和伽马相机成像等各种影像技术中至关重要，有助于慢性疾病的精确诊断和分期。根据美国国家卫生统计中心的数据，慢性病是指持续三个月或更长的疾病。大约 4000 万美国人由于一种或多种慢性健康状况而导致日常活动受到限制。混合成像技术的日益普及为市场带来了成长机会。然而，生产和基础设施的高成本可能会阻碍市场成长。

诊断放射性同位素市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 9.81% 左右的复合年增长率成长

根据放射性同位素细分，预计 Technetium-99m 将在 2023 年显示最大的市场份额

从应用细分来看，肿瘤学是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

诊断放射性同位素市场細項分析：

全球诊断放射性同位素市场根据放射性同位素、应用、成像方式、最终用户和地区进行细分。

根据放射性同位素，市场分为五个部分：Technetium-99m、铊-201、镓-67、碘-123、FDG、铷-82 等。 Technetium-99m 在市场上占有最大份额。 Technetium-99m (Tc-99m) 是一种在核医学诊断影像中广泛使用的放射性同位素。

根据应用，市场分为两类：肿瘤学、心臟病学和其他。肿瘤学在市场上占有最大份额。诊断放射性同位素在肿瘤学中使用的不同影像技术中至关重要，有助于肿瘤检测和表征、疾病进展评估和治疗反应评估。

根据影像模式，市场分为三类：SPECT、PET 和 Beta 发射器。每种影像方式都使用不同的放射性同位素来观察体内的生物过程和结构，有助于癌症等不同疾病的诊断、分期、治疗计划和监测。

根据最终用户，市场分为四类：医院、专科诊所、诊断中心、学术和研究机构以及其他机构。每个最终用户群体对利用放射性同位素的诊断成像服务都有独特的需求和需求。

诊断放射性同位素市场 - 地理洞察

该市场在地理上广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据参与商业活动的国家进一步划分。市场的成长预计将由北美推动，主要是由于核医学投资的增加。鼓膜造口产品市场主要集中于耳部感染的治疗和相关耳鼻喉科手术，而核子医学则以放射性同位素的医学影像和诊断为中心。在美国，每年进行超过 2,000 万例核医手术，而在欧洲，这一数字约为 1,000 万例，其中 200 万例为治疗性手术。展望未来，欧洲预计将成为市场成长的驱动力，这主要归功于诊断成像方式的进步。

诊断放射性同位素市场-竞争格局：

诊断放射性同位素市场的特点是竞争激烈，各公司努力确保稳定可靠的高品质放射性同位素供应。他们还专注于提供高效的影像解决方案，遵守安全和监管准则，并促进创新，以满足医疗保健专业人员和患者不断变化的需求。此外，该市场的竞争围绕着放射性製药公司提供的放射性同位素产品的品质、可靠性和品种。我们也追求技术进步，以提高生产效率、降低成本并确保符合安全和监管标准。

最近的发展：

西门子 Healthineers 宣布决定关闭其 Fast Track Diagnostics 部门，该部门是诊断业务的一个部门，提供聚合酶链反应 (PCR) 检测产品。这个特殊的产品组合主要在欧洲销售。自 COVID-19 大流行高峰以来，对这些产品的需求已大幅下降。

医学影像的另一个进展是正子断层扫描 (PET)，这是一种利用迴旋加速器中产生的同位素的高精度和先进技术。透过引入正电子发射放射性核素（通常透过注射），它会积聚在目标特定组织中。

目录

第 1 章：诊断放射性同位素市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 放射性同位素诊断放射性同位素市场片段
    • 按应用分類的诊断放射性同位素市场片段
    • 按成像方式分類的诊断放射性同位素市场片段
    • 最终用户的诊断放射性同位素市场片段
    • 按国家/地区分類的诊断放射性同位素市场片段
    • 按地区分類的诊断放射性同位素市场片段
  • 竞争洞察

第 3 章：诊断放射性同位素主要市场趋势

  • 诊断放射性同位素市场驱动因素
    • 市场驱动因素的影响分析
  • 诊断放射性同位素市场限制
    • 市场限制影响分析
  • 诊断放射性同位素市场机会
  • 诊断放射性同位素市场未来趋势

第 4 章：诊断放射性同位素产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：诊断放射性同位素市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：诊断放射性同位素市场格局

  • 2023 年诊断放射性同位素市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：诊断放射性同位素市场 - 按放射性同位素

  • 概述
    • 按放射性同位素分類的细分市占率分析
    • 锝-99m
    • 铊201
    • 镓67
    • 碘123
    • 脱氧葡萄糖
    • 铷82
    • 其他的

第 8 章：诊断放射性同位素市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肿瘤学
    • 心臟病学
    • 其他

第 9 章：诊断放射性同位素市场 - 依影像方式

  • 概述
    • 按成像方式分類的细分市场份额分析
    • SPECT
    • 宠物
    • 贝塔发射器

第 10 章：诊断放射性同位素市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 专科诊所
    • 诊断中心
    • 学术及研究机构
    • 其他的

第 11 章：诊断放射性同位素市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美诊断放射性同位素主要製造商
    • 北美市场规模和预测（按国家）
    • 北美洲市场规模与预测（按放射性同位素）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按成像方式）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲诊断放射性同位素主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲放射性同位素市场规模与预测
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按成像方式）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区诊断放射性同位素主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区放射性同位素市场规模与预测
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依影像方式）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲诊断放射性同位素主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按放射性同位素）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（以成像方式）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲诊断放射性同位素主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按放射性同位素）
    • 中东和非洲市场规模及预测（按应用）
    • 中东及非洲市场规模及预测（依影像方式）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 诊断放射性同位素产业

  • 竞争仪表板
  • 公司简介
    • GE Healthcare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Cardinal Health
    • Lantheus Holdings, Inc.
    • Bayer AG
    • Bracco
    • Eckert & Ziegler
    • Nordion (Canada) Inc.
    • NTP Radioisotopes
    • Curium, Jubilant Life Sciences Ltd
    • Isotopia Molecular Imaging Ltd.
    • Mallinckrodt Nuclear Medicine LLC
    • Jubilant DraxImage Inc.
    • Sumitomo Heavy Industries, Ltd.
    • Telix Pharmaceuticals Limited
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2460

REPORT HIGHLIGHT

Diagnostic Radioisotopes Market size was valued at USD 5,820.21 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

Diagnostic radioisotopes are radioactive isotopes that are employed in medical imaging for the purpose of diagnosing various medical conditions and diseases. These particular radioisotopes emit gamma rays, which can be detected by specialized imaging equipment like gamma cameras or PET scanners. The administration of these radioisotopes to patients is typically done through oral ingestion, intravenous injection, or inhalation, depending on the specific imaging procedure and the organ or tissue under examination. Despite their radioactive nature, the doses utilized in diagnostic imaging are extremely small and are considered safe for patients. In fact, the advantages of diagnostic imaging with radioisotopes often outweigh the potential risks associated with radiation exposure.

Diagnostic Radioisotopes Market- Market Dynamics

Rising Prevalence of Chronic Diseases is anticipated to propel the market growth

Chronic illnesses like cancer, heart diseases, and neurological disorders often necessitate frequent diagnostic imaging for monitoring disease progression, evaluating treatment effectiveness, and identifying recurrence. Diagnostic radioisotopes are essential in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma camera imaging, facilitating precise diagnosis and staging of chronic illnesses. According to the U.S. National Center for Health Statistics, a chronic disease is one that lasts for three months or more. Approximately 40 million Americans have limitations in their daily activities due to one or more chronic health conditions. The increasing adoption of hybrid imaging technologies presents a growth opportunity for the market. However, the high cost of production and infrastructure may hinder market growth.

Diagnostic Radioisotopes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Radioisotope segmentation, Technetium-99m was predicted to show maximum market share in the year 2023

Based on application segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Diagnostic Radioisotopes Market- Segmentation Analysis:

The Global Diagnostic Radioisotopes Market is segmented on the basis of Radioisotope, Application, Imaging Modality, End-user and Region.

The market is segmented into five divisions according to Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others. Technetium-99m holds the largest share in the market. Technetium-99m (Tc-99m) is a highly utilized radioisotope in nuclear medicine for diagnostic imaging.

The market is segmented into two categories according to application: Oncology, Cardiology, and Other. Oncology holds the largest share in the market. Diagnostic radioisotopes are crucial in different imaging techniques utilized in oncology, assisting in tumor detection and characterization, disease progression assessment, and treatment response evaluation.

The market is segmented into three categories according to Imaging Modality: SPECT, PET, and Beta Emitters. Each imaging modality uses distinct radioisotopes to observe biological processes and structures in the body, aiding in the diagnosis, staging, treatment planning, and monitoring of different diseases, such as cancer.

The market is segmented into four categories according to End-user: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Other establishments. Each end-user group has unique needs and demands for diagnostic imaging services that make use of radioisotopes.

Diagnostic Radioisotopes Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be driven by North America, primarily due to increasing investments in nuclear medicine. The Tympanostomy Products market mainly focuses on the treatment of ear infections and related otolaryngology procedures, while nuclear medicine is centered around medical imaging and diagnosis using radioisotopes. In the United States, there are over 20 million nuclear medicine procedures conducted annually, while in Europe, the number is around 10 million, with 2 million of them being therapeutic procedures. Looking ahead, Europe is projected to be the driving force behind the market's growth, mainly due to advancements in diagnostic imaging modalities.

Diagnostic Radioisotopes Market- Competitive Landscape:

The Diagnostic Radioisotopes Market is characterized by intense competition, with companies striving to ensure a steady and dependable supply of high-quality radioisotopes. They also focus on providing efficient imaging solutions, adhering to safety and regulatory guidelines, and fostering innovation to meet the evolving needs of healthcare professionals and patients. Additionally, competition in this market revolves around the quality, reliability, and variety of radioisotope products offered by radio pharmaceutical companies. Technological advancements are also pursued to improve production efficiency, lower costs, and ensure compliance with safety and regulatory standards.

Recent Developments:

Siemens Healthineers has announced its decision to close down its Fast Track Diagnostics unit, a division within the Diagnostics business that offers polymerase chain reaction (PCR) testing products. This particular portfolio is primarily sold in Europe. The demand for these products has significantly declined since the peak of the COVID-19 pandemic.

Another advancement in medical imaging is positron emission tomography (PET), a highly accurate and advanced technique that utilizes isotopes generated in a cyclotron. By introducing a positron-emitting radionuclide, typically through injection, it accumulates in the specific tissue being targeted.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Cardinal Health

Lantheus Holdings, Inc.

Bayer AG

Bracco

Eckert & Ziegler

Nordion (Canada) Inc.

NTP Radioisotopes

Curium, Jubilant Life Sciences Ltd

Isotopia Molecular Imaging Ltd.

Mallinckrodt Nuclear Medicine LLC

Jubilant DraxImage Inc.

Sumitomo Heavy Industries, Ltd.

Telix Pharmaceuticals Limited

Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032

  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiology
  • Other

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032

  • SPECT
  • PET
  • Beta Emitters

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Diagnostic Radioisotopes Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Diagnostic Radioisotopes Market Snippet by Radioisotope
    • 2.1.2.Diagnostic Radioisotopes Market Snippet by Application
    • 2.1.3.Diagnostic Radioisotopes Market Snippet by Imaging Modality
    • 2.1.4.Diagnostic Radioisotopes Market Snippet by End-User
    • 2.1.5.Diagnostic Radioisotopes Market Snippet by Country
    • 2.1.6.Diagnostic Radioisotopes Market Snippet by Region
  • 2.2.Competitive Insights

3.Diagnostic Radioisotopes Key Market Trends

  • 3.1.Diagnostic Radioisotopes Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Diagnostic Radioisotopes Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Diagnostic Radioisotopes Market Opportunities
  • 3.4.Diagnostic Radioisotopes Market Future Trends

4.Diagnostic Radioisotopes Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Diagnostic Radioisotopes Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Diagnostic Radioisotopes Market Landscape

  • 6.1.Diagnostic Radioisotopes Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Diagnostic Radioisotopes Market - By Radioisotope

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
    • 7.1.2.Technetium-99m
    • 7.1.3.Thallium-201
    • 7.1.4.Gallium-67
    • 7.1.5.Iodine-123
    • 7.1.6.FDG
    • 7.1.7.Rubidium-82
    • 7.1.8.Others

8.Diagnostic Radioisotopes Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Oncology
    • 8.1.3.Cardiology
    • 8.1.4.Other

9.Diagnostic Radioisotopes Market - By Imaging Modality

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Imaging Modality, 2023 & 2032 (%)
    • 9.1.2.SPECT
    • 9.1.3.PET
    • 9.1.4.Beta Emitters

10.Diagnostic Radioisotopes Market - By End-User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2.Hospitals
    • 10.1.3.Specialty Clinics
    • 10.1.4.Diagnostic Centers
    • 10.1.5.Academic & Research Institutes
    • 10.1.6.Others

11.Diagnostic Radioisotopes Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Diagnostic Radioisotopes Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Diagnostic Radioisotopes Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Diagnostic Radioisotopes Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Diagnostic Radioisotopes Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Diagnostic Radioisotopes Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Diagnostic Radioisotopes Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.GE Healthcare
    • 12.2.2.Siemens Healthineers
    • 12.2.3.Koninklijke Philips N.V.
    • 12.2.4.Cardinal Health
    • 12.2.5. Lantheus Holdings, Inc.
    • 12.2.6.Bayer AG
    • 12.2.7.Bracco
    • 12.2.8. Eckert & Ziegler
    • 12.2.9.Nordion (Canada) Inc.
    • 12.2.10.NTP Radioisotopes
    • 12.2.11.Curium, Jubilant Life Sciences Ltd
    • 12.2.12.Isotopia Molecular Imaging Ltd.
    • 12.2.13.Mallinckrodt Nuclear Medicine LLC
    • 12.2.14.Jubilant DraxImage Inc.
    • 12.2.15.Sumitomo Heavy Industries, Ltd.
    • 12.2.16.Telix Pharmaceuticals Limited
    • 12.2.17.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diagnostic Radioisotopes Market: Radioisotope Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Radioisotope
  • TABLE Global Diagnostic Radioisotopes Market, by Radioisotope 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Diagnostic Radioisotopes Market, by Application 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Imaging Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Imaging Modality
  • TABLE Global Diagnostic Radioisotopes Market, by Imaging Modality 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Diagnostic Radioisotopes Market, by End-User 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diagnostic Radioisotopes Market, by Region 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)